However, whether LRRK2 mutations cause PD and degeneration of DA neurons <i>via</i> a toxic gain-of-function or a loss-of-function mechanism is unresolved and has pivotal implications for LRRK2-based PD therapies. The gene discussed is LRRK2; the disease is Parkinson disease.